Pathalys Pharma, Inc. develops therapeutics for the management of chronic kidney disease (CKD).

Pathalys

Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.

Catalys Pacific

DaVita Venture Group

Abingworth

OrbiMed

The Carlyle Group

Pathalys Pharma

Pathalys Pharma Secures $105 Million Series B Financing - https://bit.ly/4fUovtu #Innovation #kidneydisease #finance

COM:PATHALYS

Pathalys

Analysis Not Available